Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation

JACC Cardiovasc Interv. 2019 Sep 9;12(17):1745-1747. doi: 10.1016/j.jcin.2019.04.029. Epub 2019 May 21.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Multicenter Study
  • Observational Study

MeSH terms

  • Cardiovascular Agents / administration & dosage*
  • Cardiovascular Agents / adverse effects
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / therapy*
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / epidemiology*
  • Drug-Eluting Stents*
  • Humans
  • Italy / epidemiology
  • Percutaneous Coronary Intervention / adverse effects
  • Percutaneous Coronary Intervention / instrumentation*
  • Prosthesis Design
  • Registries
  • Risk Assessment
  • Risk Factors
  • Sirolimus / administration & dosage
  • Sirolimus / adverse effects
  • Sirolimus / analogs & derivatives*
  • Time Factors
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • umirolimus
  • Sirolimus